Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04267991
Other study ID # Hamaky5
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2018
Est. completion date April 15, 2020

Study information

Verified date May 2020
Source Benha University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced vision, photophobia, glare, halos, and foreign body sensation.


Description:

first group of patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.S econd group underwent transepithelial PTK for subepithelial infiltrates. Baseline and post-treatment full ophthalmic examination was done.


Recruitment information / eligibility

Status Completed
Enrollment 63
Est. completion date April 15, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- adenoviral SEI

Exclusion Criteria:

- Other corneal diseases

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Tacrolimus ointment
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
Procedure:
phototherapeutic keratectomy
Patients underwent transepithelial PTK for subepithelial infiltrates.

Locations

Country Name City State
United Arab Emirates INMC Abu Dhabi

Sponsors (1)

Lead Sponsor Collaborator
Benha University

Country where clinical trial is conducted

United Arab Emirates, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes of corneal densitometry Sub epithelial infiltrates was examined with the densitometry programme of the Pentacam (Fa. Oculus,Weimar, Germany) 6 months
See also
  Status Clinical Trial Phase
Completed NCT05114928 - Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
Recruiting NCT06160960 - Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome
Completed NCT00357435 - Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
Completed NCT04484402 - Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells Phase 1/Phase 2
Not yet recruiting NCT05581875 - A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory Phase 1/Phase 2
Recruiting NCT06101017 - Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
Withdrawn NCT03421548 - Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1 N/A
Withdrawn NCT05700864 - NGF Treatment for Patients With Neuropathic Corneal Pain Phase 1
Enrolling by invitation NCT05758753 - QST for Corneal Nerve Function N/A
Terminated NCT00001310 - Tissue Studies of Human Eye Diseases
Completed NCT02386774 - Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa N/A
Recruiting NCT05694247 - Study to Evaluate the Clinical Safety and Performance of the CorNeat KPro for Treatment of Corneal Blindness N/A
Not yet recruiting NCT06294015 - Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops. Phase 4
Completed NCT00654888 - Automated Lamellar Keratectomy in Symptomatic Patients With Bullous Keratopathy N/A
Recruiting NCT04251143 - Dresden Corneal Disease and Treatment Study
Withdrawn NCT02374723 - Evaluation of Biosynthetic Constructs to Replace Donor Corneas Phase 1
Completed NCT01384487 - Nidek RS3000 Comparative Study N/A
Completed NCT00804505 - Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study N/A
Completed NCT04475900 - Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics
Recruiting NCT05573802 - A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma Phase 1/Phase 2